Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Renya Nishimori"'
Autor:
Atsuomi Kimura, Seiya Utsumi, Akihiro Shimokawa, Renya Nishimori, Rie Hosoi, Neil J. Stewart, Hirohiko Imai, Hideaki Fujiwara
Publikováno v:
Cancers, Vol 14, Iss 24, p 6070 (2022)
Hyperpolarized 129Xe (HP 129Xe) MRI enables functional imaging of various lung diseases but has been scarcely applied to lung cancer imaging. The aim of this study is to investigate the feasibility of targeted imaging of lung cancer with HP 129Xe MRI
Externí odkaz:
https://doaj.org/article/e90cbe454b1e4fe19fa42e0ec77b7edd
Autor:
Yoshihiro Kamada, Hirohiko Imai, Renya Nishimori, Hideaki Fujiwara, Neil J. Stewart, Akihiro Shimokawa, Atsuomi Kimura, Seiya Utsumi
Publikováno v:
Contrast Media & Molecular Imaging
Contrast Media & Molecular Imaging, Vol 2021 (2021)
Contrast Media & Molecular Imaging, Vol 2021 (2021)
This study aimed to assess the suitability of hyperpolarized 129Xe (HPXe) MRI for noninvasive longitudinal evaluation of pulmonary function in preclinical lung cancer models. A mouse model of lung cancer (LC) was induced in 5 mice by intraperitoneal
Autor:
Akihiro Shimokawa, Yukiko Yamauchi, Atsuomi Kimura, Hirohiko Imai, Neil J. Stewart, Mami Yamane, Shota Hodono, Hideaki Fujiwara, Renya Nishimori
Publikováno v:
Magnetic Resonance in Medical Sciences. 17:331-337
Purpose: High Mobility Group Box1 (HMGB1), which is one of the damage-associated molecular pattern molecules relating to various inflammatory diseases, has gained interest as a therapeutic target because of its involvement in wound healing processes.
Autor:
Atsuomi Kimura, Seiya Utsumi, Akihiro Shimokawa, Renya Nishimori, Stewart, Neil J., Yoshihiro Kamada, Hirohiko Imai, Hideaki Fujiwara
Publikováno v:
Contrast Media & Molecular Imaging; 6/29/2021, p1-10, 10p
Autor:
Shota, Hodono, Akihiro, Shimokawa, Neil J, Stewart, Yukiko, Yamauchi, Renya, Nishimori, Mami, Yamane, Hirohiko, Imai, Hideaki, Fujiwara, Atsuomi, Kimura
Publikováno v:
Magnetic Resonance in Medical Sciences
Purpose: High Mobility Group Box1 (HMGB1), which is one of the damage-associated molecular pattern molecules relating to various inflammatory diseases, has gained interest as a therapeutic target because of its involvement in wound healing processes.